SUM229PE

Information for SUM229PE

Description

Human breast cancer cell line from a primary tumor.

Source BRENDA Tissue Ontology (BTO)

ReMap Statistics

Datasets
4
Transcriptional Factors
1
Peaks
113,498
Non-redundant peaks
62,473

Description

Cell_name
SUM229PE
Category
Cancer cell line
Disease
NCIt; C4872; Breast carcinoma
Sex_gender_of_cell
Female

External IDs

Cellosaurus
CVCL_5594
Experimental Factor
EFO_0006762
BRENDA Tissue
Wiki
SUM229PE
ATCC
SUM229PE
Synonyms
229PE; SUM 229; SUM 229PE; SUM-229; SUM-229PE; SUM229
All peaks SUM229PE
Download BED file
Non redundant SUM229PE
Download BED file
CRMs SUM229PE
Download BED file
DOWNLOAD All ReMap
Go to catalogue

Datasets Table for SUM229PE

Biotype Biotype modification Ecotype Target name Target modification Source Species Experiment Peaks
SUM229PE neg_30nMtrametinib_24h BRD4 GEO Homo sapiens GSE87418 Download (34,743)
SUM229PE neg_DMSO_24h BRD4 GEO Homo sapiens GSE87418 Download (27,764)
SUM229PE pos_30nMtrametinib_24h BRD4 GEO Homo sapiens GSE87418 Download (21,232)
SUM229PE pos_DMSO_24h BRD4 GEO Homo sapiens GSE87418 Download (29,759)
Biotype Biotype modification Ecotype Target name Target modification Source Species Experiment Peaks

ReMap is a database of transcriptional regulators peaks derived from curated ChIP-seq, ChIP-exo, DAP-seq experiments in Human and Thaliana.

You are using the 2020 ReMap (3rd) release.
The ReMap catalogues (2020, 2018, 2015) are under CC BY-NC 4.0 international license, while ReMapEnrich, remap-pipeline under GNU GPLv3 licence.

Inserm TAGC
AMU AMU-MESO

This work was granted access to the HPC resources of Aix-Marseille Université financed by the project Equip@Meso (ANR-10-EQPX-29-01) of the program "Investissements d’Avenir" supervised by the Agence Nationale de la Recherche.